Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03571776Not ApplicableTerminated
Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial
EndometriomaFertility Disorders
PrincipalinvestigatorStart date: 2018-06-05
NCT02669628Completed
Antimullerian Hormone in Endometriomas
Endometriomas
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Hospital de Bellvitge. IDIBELL

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03571776Not ApplicablePrincipalInvestigator

Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial

EndometriomaFertility Disorders
Terminated
NCT02669628PrincipalInvestigator

Antimullerian Hormone in Endometriomas

Endometriomas
Completed

All 2 trials loaded